How to get a good night’s sleep
Sleeping is sometimes a more complex affair than we imagine. A discussion by Michael H. Silber, a neurologist of the Mayo Clinic College of Medicine in the US, explains some of the problems of chronic insomnia in an article in the New England Journal of Medicine for 25 August. He defines insomnia as “difficulty with the initiation, maintenance, duration or quality of sleep that results in the impairment of daytime functioning, despite adequate opportunity and circumstances for sleep”. An arbitrary delay of more than 30 minutes of sleep onset or less than 85 per cent of time asleep to time spent in bed is often assumed, but in fact subjective judgement of sleep quality and quantity is more important from the clinical angle.
Chronic insomnia lasting more than one month has an incidence of 10 to 15 per cent, It more frequently affects women, older adults and patients suffering from chronic medical and psychiatric disorders. It may result in fatigue, mood disturbances, problems with interpersonal relationships, occupational difficulties and a reduced quality of life.
Insomnia may be classified as primary or secondary. The first has an uncertain pathology, but is probably a state of hyper-arousal, with a higher metabolic rate and high secretion of adrenocorticotrophic hormone and cortisol. The second involves adjustment, possibly to the effect of a drug or food substance.
Treatment may involve cognitive behavioural therapy to counteract habits that induce insomnia. In primary insomnia such therapy is efficacious, when administered by a psychologist over six sessions, each roughly one hour. Trained primary care doctors or nurses can successfully administer the treatment over up to 10 sessions. Pharmacological treatment involves benzodiazepines, benzodiazepine-receptor agonists and sedating antidepressants. There are some doubts over the efficacy of diphenhydramine or doxylamine and melatonin.
Withdrawal effects, particularly rebound insomnia, are rare after treatment with long-duration benzodiazepines, and usually rare after the use of intermediate-acting benzodiazepines. Tricyclic antidepressants tend to induce unwanted side effects, such as dry mouth, postural hypotension, drowsiness, cardiac arrhythmias and weight gain. Combined cognitive behaviour and drug therapy is effective, the first having more prolonged benefit.
Back to Top
|